02 May 2015
Atlas Genetics Ltd., developer of innovative, ultra-rapid diagnostics to enable a ‘test and treat’ solution to infectious diseases, today announces its Annual Summary for 2014.
Google's Calico continues its partnering romp on aging R&D with Buck collaboration
30 April 2015
Google's stealthy biotech Calico is setting up shop inside the Buck Institute for Research on Aging in Novato, CA, after hammering out the latest in a long lineup of deals to collaborate on a new generation of therapeutics.
Here's an M&A strategy: Buy products, hike prices, watch sales grow
29 April 2015
As the M&A wave sweeps over pharma, companies are wheeling and dealing for a number of different reasons. Slim-down strategies, tax break potential, portfolio diversification and other usual suspects have all driven transactions as of late--but the promise of price hikes has, too.
China hopes to learn ins and outs of regulation from U.S. FDA
29 April 2015
China's FDA is laying plans to work directly with its U.S. counterpart to learn the secrets of drug and medical-device regulation and bring China drugmaking and other regulated industries up to international standards.
India mulls adopting international standards on drug inspections, manufacturing
29 April 2015
India's pharmaceutical regulators are considering whether to take the rigid steps necessary to join international drug inspection systems. The actions are considered necessary if India is to become more of an exporting nation, but some pharmas are cautious.
28 April 2015
Spark Therapeutics, Inc. (NASDAQ: ONCE) and Clearside Biomedical, Inc. announced today that they have entered into an option agreement under which Spark acquired exclusive rights to license Clearside's microinjector technology to deliver gene therapies to the back of the eye. Under the agreement, the companies will explore the feasibility of using Clearside's microinjector technology to deliver viral vectors to the choroid and the retina through the suprachoroidal space (SCS).
Pharmaceutical Companies Buy Rivals’ Drugs, Then Jack Up the Prices
28 April 2015
More pharmaceutical companies are buying drugs that they see as undervalued, then raising the prices. It is one of a number of industry tactics, along with companies regularly upping the prices of their own older medicines and launching new treatments at once unheard of sums, driving up the cost of drugs.
Virus Protects From Other Viruses
28 April 2015
An ancient retrovirus that's been integrated into the human genome appears to become reactivated during embryonic development to help ward off other viral invaders, Carl Zimmer writes at the New York Times.
Decline in U.S. science spending threatens economy, security: MIT
28 April 2015
Warning of an "innovation deficit," scientists at the Massachusetts Institute of Technology say declining government spending on basic research is holding back potentially life-saving advances in 15 fields, from robotics and fusion energy to Alzheimer's disease and agriculture.
Why Cross-Country Comparisons on Drug Prices are Misleading
28 April 2015
Too often, critics greatly exaggerate price differences between the U.S. and other countries to create an erroneous impression that medicines are a major driver of U.S. health care cost growth – ignoring that medicines account for a small share of health spending differences between the U.S. and other countries. They also fail to acknowledge the ramifications of centralized price control policies other countries use to achieve whatever price differences do exist.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024